REFERENCE
Dranitsaris G, Stumpo C, Smith R, Bartle W.Extended dalteparin prophylaxis for venous thromboembolic events: cost-utility analysis in patients undergoing major orthopedic surgery. American Journal of Cardiovascular Drugs 9: 45-58, No. 1, 2009
Rights and permissions
About this article
Cite this article
Dalteparin cost-effective for postop DVT prophylaxis. Pharmacoecon. Outcomes News 573, 8 (2009). https://doi.org/10.2165/00151234-200905730-00022
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905730-00022